Experimental Therapeutics Institute

About the Experimental Therapeutics Institute

Experimental Therapeutics Institute (ETI) at the Icahn School of Medicine at Mount Sinai in New York City is a hub for the development of new drugs that result from the Mount Sinai Health System’s basic and clinical research programs. The Institute offers an integrated collaborative approach utilizing HT systems to model and validate novel biological discoveries. The capabilities are:

In collaboration with Mount Sinai investigators, as well as external partners, we are able to design and execute projects to delivery proof-of-concept candidates. We meet with investigators and discuss whether the activity is fee-for-service or a unique opportunity to collaborate to develop a novel therapeutic. In the case of the latter, ETI will work with the PI to develop an experimental plan and apply for a grant or collaboration.